November 15, 2021 -- Thermo Fisher Scientific plans to highlight its proteomics solutions and collaboration with industry experts at the virtual Human Proteome Organization Reconnect 2021 meeting.
Proteomics research shows promise for discovering new biomarkers for disease diagnosis, the company said. Thermo Fisher is extending its co-marketing agreement with Biognosys for that company's PQ500 Reference Peptide Kit, which can quantify more than 500 proteins in human plasma/serum samples and can be used with Thermo Scientific's Orbitrap Exploris 480 mass spectrometer.
Thermo Fisher will also highlight its Thermo Scientific Vanquish Neo Ultra-High Performance Liquid Chromatography system, which works with Orbitrap for proteomics analyses.
Finally, the company has boosted its chromatography offerings through the purchase of PharmaFluidics, a μPAC microchip-based chromatography column developer, and has brokered another expanded co-marketing agreement with Cellenion, a single-cell sample preparation developer.